| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―12 |
Effect of Regdanvimab on Mortality in Patients Infected with SARS-CoV-2 Delta Variants: A Propensity Score-Matched Cohort Study |
Soyoon Hwang, Nan Young Lee, Eunkyung Nam, Yu Kyung Kim, Shin-Woo Kim, Hyun-Ha Chang, Yoonjung Kim, Sohyun Bae, Juhwan Jeong, Jae-Ho Shin, Guehwan Jang, Changhee Lee, Ki Tae Kwon |
| 2 |
[GO] |
2024―Mar―18 |
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-Analysis Using the GRADE Framework |
Sushma Kavikondala, Katrin Haeussler, Xuan Wang, Mary T. Bausch-Jurken, Maria Nassim, Nitendra Kumar Mishra, Mia Malmenäs, Pawana Sharma, Nicolas Van de Velde, Nathan Green, Ekkehard Beck |
| 3 |
[GO] |
2024―Mar―18 |
Evaluating the Demand for Nucleic Acid Testing in Different Scenarios of COVID-19 Transmission: A Simulation Study |
Yu-Yuan Wang, Wei-Wen Zhang, Ze-xi Lu, Jia-lin Sun, Ming-xia Jing |
| 4 |
[GO] |
2024―Mar―15 |
K-Means Clustering Identifies Diverse Clinical Phenotypes in COVID-19 Patients: Implications for Mortality Risks and Remdesivir Impact |
Carolina Garcia-Vidal, Christian Teijón-Lumbreras, Tommaso Francesco Aiello, Mariana Chumbita, Rosario Menendez, Aina Mateu-Subirà, Olivier Peyrony, Patricia Monzó, Carlos Lopera, Antonio Gallardo-Pizarro, Raúl Méndez, Esther Calbo, Mariona Xercavins, Genoveva Cuesta-Chasco, José A. Martínez, Ma Angeles Marcos, Josep Mensa, Alex Soriano |
| 5 |
[GO] |
2024―Mar―10 |
Longitudinal Molecular and Serological Evidence of SARS-CoV-2 Infections and Vaccination Status: Community-Based Surveillance Study (CONTACT) |
Olga Sánchez-Soliño, Ryan D. Kilpatrick, Christopher Johnson, Yixin Fang, Yizhou Ye, Negar Niki Alami, Katarzyna Zarish, Whitney S. Krueger, Nancy Dreyer, Gregory C. Gray |
| 6 |
[GO] |
2024―Mar―09 |
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor |
Takayuki Katsube, Safwan Kezbor, Ryosuke Shimizu, Ryuji Kubota |
| 7 |
[GO] |
2024―Mar―08 |
Living During COVID-19 While Immunocompromised: A Patient and Physician Perspective from France |
Elise Foudrat, Sophie Caillard |
| 8 |
[GO] |
2024―Mar―05 |
The Impact of the COVID-19 Pandemic on the Incidence of Herpes Zoster: A Narrative Literature Review |
Raunak Parikh, Mitra Yousefi, Desmond Curran, Robyn Widenmaier |
| 9 |
[GO] |
2024―Feb―25 |
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial |
F. D. Richard Hobbs, Hugh Montgomery, Francisco Padilla, Jesus Abraham Simón-Campos, Douglas Arbetter, Seth Seegobin, Alexandre Kiazand, Katie Streicher, Nuria Martinez-Alier, Taylor S. Cohen, Mark T. Esser |
| 10 |
[GO] |
2024―Jan―30 |
Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab or Sotrovimab on Persistently High Viral Load in Patients with Mild-to-Moderate COVID-19: A Randomized, Phase 2 BLAZE-4 Trial |
Russell M. Nichols, Lisa Macpherson, Dipak R. Patel, Wendy W. Yeh, Amanda Peppercorn |
| 11 |
[GO] |
2024―Jan―17 |
Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan |
Shohei Shinozaki, Asuka Watanabe, Masahiro Kimata, Makoto Miyazaki, Shinichiroh Maekawa |
| 12 |
[GO] |
2024―Jan―13 |
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System |
Haley J. Appaneal, Kerry L. LaPlante, Vrishali V. Lopes, Catherine Martin, Laura Puzniak, Timothy L. Wiemken, Evan J. Zasowski, John M. McLaughlin, Aisling R. Caffrey |
| 13 |
[GO] |
2024―Jan―09 |
Remdesivir for the Treatment of COVID-19: A Narrative Review |
Patrick O. Godwin, Bryan Polsonetti, Michael F. Caron, Thomas F. Oppelt |
| 14 |
[GO] |
2023―Dec―16 |
Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies |
Chris Wynne, Abundio Balgos, Jingxin Li, Paul Hamilton, Louie Tirador, Anjuli May Jaen, Chen Mo, Zijing Yue, Ying Ma, Qingshuang Wang, Rendu Wen, Zheng Yao, Jiaping Yu, Wenrong Yao, Jianhui Zhang, Hui Zheng, Kunxue Hong, Fengcai Zhu, Yong Liu |
| 15 |
[GO] |
2023―Dec―01 |
Safety and Immunogenicity of Homologous Recombinant Adenovirus Type 5-Vectored COVID-19 Vaccine Booster Dose in Healthy Adults Aged 18-60 Years: a Single-Center, Open-Label Trial |
Siyue Jia, Jinlong Zhang, Xue Wang, Zhe Zhang, Busen Wang, Jun Zhang, Hudachuan Jiang, Ge Guo, Ying Wang, Jingxuan Wan, Wenjuan Wang, Lihua Hou, Fengcai Zhu |
| 16 |
[GO] |
2023―Nov―23 |
Virologic Outcomes with Molnupiravir in Non-hospitalized Adult Patients with COVID-19 from the Randomized, Placebo-Controlled MOVe-OUT Trial |
Julie M. Strizki, Jay A. Grobler, Nicholas Murgolo, Arthur Fridman, Matthew G. Johnson, Jiejun Du, Patricia Carmelitano, Michelle L. Brown, Amanda Paschke, Carisa De Anda |
| 17 |
[GO] |
2023―Nov―02 |
Analysis of SARS-CoV-2 Emergent Variants Following AZD7442 (Tixagevimab/Cilgavimab) for Early Outpatient Treatment of COVID-19 (TACKLE Trial) |
Gustavo H. Kijak, Bahar Ahani, Douglas Arbetter, Fernando Chuecos, Vancheswaran Gopalakrishnan, Jagadish Beloor, Tyler Brady, Amy Nguyen, Tiffany L. Roe, Nicolette Schuko, Tianhui Zhang, F. D. Richard Hobbs, Francisco Padilla, Elizabeth J. Kelly, Hugh Montgomery, Katie Streicher |
| 18 |
[GO] |
2023―Oct―13 |
Safety and Effectiveness of Regdanvimab for COVID-19 Treatment: A Phase 4 Post-marketing Surveillance Study Conducted in South Korea |
Ji Yeon Lee, Seon Hee Bu, EunHyang Song, Seongcheol Cho, Sungbong Yu, Jungok Kim, Sungmin Kym, Kwang Won Seo, Ki Tae Kwon, Jin Yong Kim, Sunghyun Kim, Keumyoung Ahn, Nahyun Jung, Yeonmi Lee, Yoobin Jung, Chankyoung Hwang, Sang Won Park |
| 19 |
[GO] |
2023―Oct―06 |
Rapid Response to Remdesivir in Hospitalised COVID-19 Patients: A Propensity Score Weighted Multicentre Cohort Study |
Emiel Leegwater, Lisa Dol, Menno R. Benard, Eveline E. Roelofsen, Nathalie M. Delfos, Machteld van der Feltz, Femke P. N. Mollema, Liesbeth B. E. Bosma, Loes E. Visser, Thomas H. Ottens, Nathalie D. van Burgel, Sesmu M. Arbous, Lahssan H. El Bouazzaoui, Rachel Knevel, Rolf H. H. Groenwold, Mark G. J. de Boer, Leo G. Visser, Frits R. Rosendaal, Erik B. Wilms, Cees van Nieuwkoop |
| 20 |
[GO] |
2023―Oct―05 |
Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study |
Lorenzo Piemonti, Giovanni Landoni, Antonio Voza, Massimo Puoti, Ivan Gentile, Nicola Coppola, Stefano Nava, Alessia Mattei, Franco Marinangeli, Giulia Marchetti, Paolo Bonfanti, Claudio Maria Mastroianni, Matteo Bassetti, Ernesto Crisafulli, Paolo Antonio Grossi, Alberto Zangrillo, Antonio Desai, Marco Merli, Maria Foggia, Marco Carpano, Lorenzo Schiavoni, Antonella D’Arminio Monforte, Luca Bisi, Gianluca Russo, Fabiana Busti, Cristina Rovelli, Elisabetta Perrotta, Giovanni Goisis, Elizabeth M. Gavioli, Sophie Toya, Maria De Pizzol, Flavio Mantelli, Marcello Allegretti, Enrico Maria Minnella |
| 21 |
[GO] |
2023―Sep―26 |
Outpatient Treatment with AZD7442 (Tixagevimab/Cilgavimab) Prevented COVID-19 Hospitalizations over 6 Months and Reduced Symptom Progression in the TACKLE Randomized Trial |
F. D. Richard Hobbs, Hugh Montgomery, Francisco Padilla, Jesus Abraham Simón-Campos, Kenneth Kim, Douglas Arbetter, Kelly W. Padilla, Venkatesh Pilla Reddy, Seth Seegobin, Katie Streicher, Alison Templeton, Rolando M. Viani, Eva Johnsson, Gavin C. K. W. Koh, Mark T. Esser |
| 22 |
[GO] |
2023―Sep―13 |
Clusters of SARS-CoV-2 Infection Across Six Schools for Students with Intellectual and Developmental Disabilities |
Michael Gemmell, Tyler Walsh, Michael Sherby, Adwoa Imbeah, Kelly Bono, Megan Baldenweck, Christina Gurnett, Jason G. Newland |
| 23 |
[GO] |
2023―Jul―24 |
Is Azvudine Comparable to Nirmatrelvir-Ritonavir in Real-World Efficacy and Safety for Hospitalized Patients with COVID-19? A Retrospective Cohort Study |
Qinqin Zhao, Bei Zheng, Bing Han, Pinpin Feng, Zhongni Xia, Hong Jiang, Yin Ying, Jun Zhu, Cheng Fei, Junlei Xiang, Lingli Shen, Qiliang Luo, Yinhuan Wu, Ayiguzhali Wusiman, Chuanwei Xin, Meiling Zhang, Gonghua Li, Xiang Li |
| 24 |
[GO] |
2023―Jun―17 |
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial |
Himanshu P. Upadhyaya, Jenny Y. Chien, Amanda J. Long, Martin S. Bohm, Nicole L. Kallewaard, Lisa F. Macpherson, Dipak R. Patel, Matthew M. Hufford, Constance J. Krull, Jocelyn Y. Ang, Peter Chen, William J. Muller, Jeffrey A. Potts, Timothy Quinn, Mark Williams, Faisal Amin, Masoud Azizad, Katherine Belden, Joseph Boscia, Yevgeniy Bukhman, Jose Cardona, Peter Chen, Paul Cook, Chad Crystal, Mike Dougan, William Fischer, Jeffrey Glassberg, Robert L. Gottlieb, Corey Herbert, Howard Huang, Gregory Huhn, Jeffery Kingsley, Princy Kumar, Anuj Malik, Carlos Malvestutto, Patrick Milligan, Bharat Mocherla, Ramesh Mohseni, Jason Morris, Ramesh Nathan, David Pitrak, Joshua Purow, Mayur Ramesh, Yessica Sachdeva, Adam Schwartz, Imad Shawa, Nader Sobh, Valentina Stosor, Charles Thompson, Omesh Verma, Erica Kaufman West, David Wheeler, Michael Winnie, Brian Zeno |
| 25 |
[GO] |
2023―May―24 |
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources |
Lianne Barnieh, Rachel Beckerman, Sushanth Jeyakumar, Alice Hsiao, James Jarrett, Robert L. Gottlieb |
| 26 |
[GO] |
2023―May―17 |
Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study |
Erika Asperges, Giuseppe Albi, Valentina Zuccaro, Margherita Sambo, Teresa C. Pieri, Matteo Calia, Marta Colaneri, Laura Maiocchi, Federica Melazzini, Angioletta Lasagna, Andrea Peri, Francesco Mojoli, Paolo Sacchi, Raffaele Bruno |
| 27 |
[GO] |
2023―Apr―25 |
Narrative Review of the Evolution of COVID-19 Vaccination Recommendations in Countries in Latin America, Africa and the Middle East, and Asia |
Júlia Spinardi, Ana Carolina Dantas, Carolina Carballo, Karan Thakkar, Nadine Al Akoury, Moe Hein Kyaw, Graciela del Carmen Morales Castillo, Amit Srivastava, Marco Aurélio P. Sáfadi |
| 28 |
[GO] |
2023―Apr―25 |
Safety, Pharmacokinetics, Serum Neutralizing Titers, and Immunogenicity of Adintrevimab, a Monoclonal Antibody Targeting SARS-CoV-2: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Dose-escalation Study in Healthy Adults |
Pete Schmidt, Jean Gong, Kristin Narayan, Deepali Gupta, Frank Engler, Yong Li, Amanda Copans, Ed Campanaro |
| 29 |
[GO] |
2023―Mar―26 |
Diagnostic Accuracy of a Rapid SARS-CoV-2 Antigen Test Among People Experiencing Homelessness: A Prospective Cohort and Implementation Study |
Pasquale De Nardo, Maela Tebon, Alessia Savoldi, Nicola Soriolo, Elisa Danese, Denise Peserico, Matteo Morra, Elisa Gentilotti, Gulser Caliskan, Pierpaolo Marchetti, Riccardo Cecchetto, Annarita Mazzariol, Giuseppe Verlato, Davide Gibellini, Evelina Tacconelli |
| 30 |
[GO] |
2023―Mar―23 |
Safety and Effectiveness of Molnupiravir (LAGEVRIO®) Capsules in Japanese Patients with COVID-19: Interim Report of Post-marketing Surveillance in Japan |
Masahiro Kimata, Asuka Watanabe, Yukiko Yanagida, Daisuke Kinoshita, Shinichiroh Maekawa |
| 31 |
[GO] |
2023―Mar―22 |
The Significance of Epidemic Plasmids in the Success of Multidrug-Resistant Drug Pandemic Extraintestinal Pathogenic Escherichia coli |
Johann D. D. Pitout, Liang Chen |
| 32 |
[GO] |
2023―Mar―08 |
A Letter to the Editor Regarding ‘Identifying Gaps in the Corticosteroid Treatment of COVID-19: We Need More Studies’ |
Fatma Yildirim, İrem Karaman, Aşkın Güneş |
| 33 |
[GO] |
2023―Feb―22 |
Systematic Review on the Correlation Between SARS-CoV-2 Real-Time PCR Cycle Threshold Values and Epidemiological Trends |
Ester Sala, Isheeta S. Shah, Davide Manissero, Marti Juanola-Falgarona, Anne-Marie Quirke, Sonia N. Rao |
| 34 |
[GO] |
2023―Feb―17 |
Monoclonal Antibodies in Hospitalised Patients with COVID-19: The Role of SARS-COV-2 Serostatus in an Evolving Pandemic |
François Raffi, Robert L. Gottlieb |
| 35 |
[GO] |
2023―Feb―16 |
Correction to: Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
Sanjeev Sinha, Anuj Ajayababu, Himanshu Thukral, Sushil Gupta, Subhasish Kamal Guha, Ayan Basu, Gaurav Gupta, Prashant Thakur, Raghavendra Lingaiah, Bimal Kumar Das, Urvashi B. Singh, Ravinder Singh, Rajiv Narang, Dipankar Bhowmik, Naveet Wig, Dolan Champa Modak, Bhaswati Bandyopadhyay, Banya Chakrabarty, Aditya Kapoor, Satyendra Tewari, Narayan Prasad, Zia Hashim, Alok Nath, Niraj Kumari, Ravinder Goswami, Shivam Pandey, Ravindra Mohan Pandey |
| 36 |
[GO] |
2023―Jan―25 |
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults |
Guiling Chen, Nan Li, Xiahong Dai, Shiyan Tu, Zhenwei Shen, Kaiqi Wu, Tinghan Jin, Jiajun Wu, Conggao Peng, Guoping Sheng, Mengfei Zhu, Lingling Tang, Lanjuan Li |
| 37 |
[GO] |
2023―Jan―25 |
Safety and Efficacy of Paxlovid Against Omicron Variants of Coronavirus Disease 2019 in Elderly Patients |
Chengzhao Weng, Rongcheng Xie, Guanjie Han, Ya Yuan, Shiqin Li, Chao Wang, Xiaofeng Wang, Wei Jiang, Libo Jiang |
| 38 |
[GO] |
2023―Jan―12 |
COVID-19 in Latin America: A Snapshot in Time and the Road Ahead |
Jorge LaRotta, Omar Escobar, María L. Ávila-Aguero, Juan Pablo Torres, Rodrigo Sini de Almeida, Graciela del Carmen Morales, Amit Srivastava |
| 39 |
[GO] |
2023―Jan―11 |
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA |
Mindy M. Cheng, Carolina Reyes, Sacha Satram, Helen Birch, Daniel C. Gibbons, Myriam Drysdale, Christopher F. Bell, Anvar Suyundikov, Xiao Ding, M. Cyrus Maher, Wendy Yeh, Amalio Telenti, Lawrence Corey |
| 40 |
[GO] |
2023―Jan―09 |
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review |
Nick Pooley, Salim S. Abdool Karim, Behazine Combadière, Eng Eong Ooi, Rebecca C. Harris, Clotilde El Guerche Seblain, Masoumeh Kisomi, Nabila Shaikh |
| 41 |
[GO] |
2023―Jan―05 |
The Association Between Alveolar-Arterial Oxygen Tension Difference and the Severity of COVID-19 in Patients |
Canbin Xie, Jiayi Deng, Fanglin Li, Chenfang Wu, Min Xu, Bo Yu, Guobao Wu, Yanjun Zhong, Da Tang, Jinxiu Li |
| 42 |
[GO] |
2023―Jan―04 |
Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19 |
Qing Meng, Wujiao Li, Hanfang Jiang, Huimin Yan, Heping Wang, Binjun Ye, Lintao Zhou, Yunsheng Chen |
| 43 |
[GO] |
2022―Dec―15 |
Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis |
Min-Taek Lee, Wonbin Choi, Seung-Hun You, Sewon Park, Jeong-Yeon Kim, Dal Ri Nam, Ju Won Lee, Sun-Young Jung |
| 44 |
[GO] |
2022―Dec―15 |
Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group |
Tomás José González-López, Abelardo Bárez, Angel Bernardo-Gutiérrez, Silvia Bernat, Mariana Canaro-Hirnyk, Laura Entrena-Ureña, Fernando Fernández-Fuertes, José María Guinea de Castro, Reyes Jiménez-Bárcenas, Cristina Pascual-Izquierdo, Blanca Sánchez-González, Isidro Jarque |
| 45 |
[GO] |
2022―Dec―10 |
Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study |
Natàlia Pallarès, Cristian Tebé, Gabriela Abelenda-Alonso, Alexander Rombauts, Isabel Oriol, Antonella F. Simonetti, Alejandro Rodríguez-Molinero, Elisenda Izquierdo, Vicens Díaz-Brito, Gemma Molist, Guadalupe Gómez Melis, Jordi Carratalà, Sebastián Videla, Carlota Gudiol, Judit Aranda-Lobo, Marta Arroyo, Carlos Pérez-López, Montserrat Sanmartí, Encarna Moreno, Maria C. Mª Alvarez, Ana Faura, Martha Gónzalez, Paula Cruz, Mireia Colom, Andrea Perez, Laura Serrano, Mireia Besalú, Erik Cobo, Jordi Cortés, Daniel Fernández, Leire Garmendia, Pilar Hereu, Klaus Langohr, Núria Pérez-Álvarez, Xavier Piulachs |
| 46 |
[GO] |
2022―Nov―28 |
Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis |
Yani Ke, Kaihan Wu, Chenglu Shen, Yuqing Zhu, Chuchu Xu, Qiushuang Li, Jie Hu, Shan Liu |
| 47 |
[GO] |
2022―Nov―28 |
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience |
Giusy Tiseo, Chiara Barbieri, Valentina Galfo, Sara Occhineri, Tommaso Matucci, Francesco Almerigogna, Jona Kalo, Pietro Sponga, Mario Cesaretti, Gabriele Marchetti, Arianna Forniti, Claudio Caroselli, Simone Ferranti, Manuela Pogliaghi, Marina Polidori, Silvia Fabiani, Stefano Verdenelli, Enrico Tagliaferri, Niccolò Riccardi, Lorenzo Roberto Suardi, Claudia Carmignani, Serena Batini, Luca Puccetti, Riccardo Iapoce, Francesco Menichetti, Marco Falcone |
| 48 |
[GO] |
2022―Nov―23 |
Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia |
Shun Ito, Masahiro Banno, Yuji Okazaki |
| 49 |
[GO] |
2022―Nov―23 |
Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia” |
Flavio Mantelli |
| 50 |
[GO] |
2022―Nov―15 |
Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19 |
Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Maha Maglinao, Udo Eichenlaub, Basel Kashlan, Rolando Pajon, Simon Jochum |
| 51 |
[GO] |
2022―Nov―04 |
Machine Learning Successfully Detects Patients with COVID-19 Prior to PCR Results and Predicts Their Survival Based on Standard Laboratory Parameters in an Observational Study |
Filip Styrzynski, Damir Zhakparov, Marco Schmid, Damian Roqueiro, Zuzanna Lukasik, Julia Solek, Jakub Nowicki, Milosz Dobrogowski, Joanna Makowska, Milena Sokolowska, Katja Baerenfaller |
| 52 |
[GO] |
2022―Oct―15 |
Efficacy of Bacillus Calmette-Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial |
Sanjeev Sinha, Anuj Ajayababu, Himanshu Thukral, Sushil Gupta, Subhasish Kamal Guha, Ayan Basu, Gaurav Gupta, Prashant Thakur, Raghavendra Lingaiah, Bimal Kumar Das, Urvashi B. Singh, Ravinder Singh, Rajiv Narang, Dipankar Bhowmik, Naveet Wig, Dolan Champa Modak, Bhaswati Bandyopadhyay, Banya Chakrabarty, Aditya Kapoor, Satyendra Tewari, Narayan Prasad, Zia Hashim, Alok Nath, Niraj Kumari, Ravinder Goswami, Shivam Pandey, Ravindra Mohan Pandey |
| 53 |
[GO] |
2022―Oct―15 |
Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial |
Maria J. G. T. Vehreschild, Petar Atanasov, Kateryna Yurko, Cristian Oancea, Georgi Popov, Valentina Smesnoi, Gheorghe Placinta, Hella Kohlhof, Daniel Vitt, Evelyn Peelen, Jelena Mihajlović, Andreas R. Muehler |
| 54 |
[GO] |
2022―Oct―11 |
PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the United States |
Liping Huang, Jennifer L. Nguyen, Tamuno Alfred, Johnna Perdrizet, Alejandro Cane, Adriano Arguedas |
| 55 |
[GO] |
2022―Oct―01 |
Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19 |
Jessica J. Jalbert, Mohamed Hussein, Vera Mastey, Robert J. Sanchez, Degang Wang, Dana Murdock, Laura Fariñas, Jonathan Bussey, Carlos Duart, Boaz Hirshberg, David M. Weinreich, Wenhui Wei |
| 56 |
[GO] |
2022―Sep―26 |
Excess of Post-Acute Sequelae of COVID-19 After the First Wave of the Pandemic |
Marc Scherlinger, Cédric Lemogne, Renaud Felten, Jean Sibilia |
| 57 |
[GO] |
2022―Sep―24 |
Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms |
Jayne E. Ellis, Poppy Guest, Vicki Lawson, Julia Loecherbach, Nigel Lindner, Andrew McCulloch |
| 58 |
[GO] |
2022―Sep―12 |
COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups |
Sherrie L. Kelly, Epke A. Le Rutte, Maximilian Richter, Melissa A. Penny, Andrew J. Shattock |
| 59 |
[GO] |
2022―Sep―04 |
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults |
Venkateshan S. Prativadibhayankaram, Lawrence Soon-U Lee, David Lye, Xu Xiaoying, Ranjani Nellore, Vishal Pendharkar, Hannes Hentze, Siyu Guan, Benjamin J. Ayers, Shirley G. K. Seah, De Hoe Chye, Najwa S. N. Talib, Nivashini Kaliaperumal, Wei Yee Ong, Zi Xin Wong, Veonice B. Au, Anshula Alok, John E. Connolly, Jerome D. Boyd-Kirkup, Piers J. Ingram, Brendon J. Hanson, Kantharaj Ethirajulu, Damian O’Connell, Conrad E. Z. Chan |
| 60 |
[GO] |
2022―Aug―25 |
Clinical Utility of Circulating Pneumoproteins as Diagnostic and Prognostic Biomarkers in COVID-19: A Systematic Review and Meta-analysis |
Yani Ke, Yuqing Zhu, Shuaihang Chen, Jie Hu, Ruilin Chen, Wu Li, Shan Liu |
| 61 |
[GO] |
2022―Aug―01 |
Herpes Simplex Virus 1 (HSV-1) Reactivation in Critically Ill COVID-19 Patients: A Brief Narrative Review |
Daniele Roberto Giacobbe, Stefano Di Bella, Antonio Lovecchio, Lorenzo Ball, Andrea De Maria, Antonio Vena, Bianca Bruzzone, Giancarlo Icardi, Paolo Pelosi, Roberto Luzzati, Matteo Bassetti |
| 62 |
[GO] |
2022―Jun―29 |
Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic |
E. Ariza-Vioque, F. Ello, H. Andriamamonjisoa, V. Machault, J. González-Martín, M. C. Calvo-Cortés, S. Eholié, G. A. Tchabert, T. Ouassa, M. Raberahona, R. Rakotoarivelo, H. Razafindrakoto, L. Rahajamanana, R. J. Wilkinson, A. Davis, M. Maxebengula, F. Abrahams, C. Muzoora, N. Nakigozi, D. Nyehangane, D. Nanjebe, H. Mbega, R. Kaitano, M. Bonnet, P. Debeaudrap, J. M. Miró, X. Anglaret, N. Rakotosamimanana, A. Calmy, F. Bonnet, J. Ambrosioni |
| 63 |
[GO] |
2022―May―26 |
A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia |
Giovanni Landoni, Lorenzo Piemonti, Antonella d’Arminio Monforte, Paolo Grossi, Alberto Zangrillo, Enrico Bucci, Marcello Allegretti, Giovanni Goisis, Elizabeth M. Gavioli, Neal Patel, Maria De Pizzol, Georgea Pasedis, Flavio Mantelli |
| 64 |
[GO] |
2022―May―25 |
Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review |
Norka I. Napuri, Daniel Curcio, David L. Swerdlow, Amit Srivastava |
| 65 |
[GO] |
2022―May―17 |
Durability and Immunogenicity of Neutralizing Antibodies Response Against Omicron Variants After Three Doses of Subunit SARS-CoV-2 Vaccine MVC-COV1901: An Extension to an Open-Label, Dose-Escalation Phase 1 Study |
Szu-Min Hsieh, Shan-Chwen Chang, Hao-Yuan Cheng, Shin-Ru Shih, Chia En Lien |
| 66 |
[GO] |
2022―May―16 |
Correction to: Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection |
Eszter Fodor, Veronika Müller, Zsolt Iványi, Tímea Berki, Olga Kuten Pella, István Hornyák, Mira Ambrus, Ágnes Sárkány, Árpád Skázel, Ágnes Madár, Dorottya Kardos, Gábor Kemenesi, Fanni Földes, Sándor Nagy, Andrea Matusovits, Janos Nacsa, Attila Tordai, Ferenc Jakab, Zsombor Lacza |
| 67 |
[GO] |
2022―May―11 |
Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19 |
Nicholas Rebold, Sara Alosaimy, Taylor Morrisette, Dana Holger, Abdalhamid M. Lagnf, Iman Ansari, Ana C. Belza, Laura Cheaney, Huzaifa Hussain, Shelbye R. Herbin, Jacinda Abdul-Mutakabbir, Caitlin Carron, Avnish Sandhu, Teena Chopra, Michael J. Rybak |
| 68 |
[GO] |
2022―May―09 |
Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study |
Nathan J. Brendish, Alex R. Tanner, Stephen Poole, Kate R. Beard, Vasanth V. Naidu, Christopher T. Mansbridge, Nicholas J. Norton, Helen Wheeler, Laura Presland, Tristan W. Clark |
| 69 |
[GO] |
2022―Apr―27 |
Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study |
Rodrigo Alonso, Ana M. Camon, Celia Cardozo, Laia Albiach, Daiana Agüero, M. Angeles Marcos, Juan Ambrosioni, Marta Bodro, Mariana Chumbita, Lorena de la Mora, Nicole Garcia-Pouton, Gerard Dueñas, Marta Hernandez-Meneses, Alexy Inciarte, Genoveva Cuesta, Fernanda Meira, Laura Morata, Pedro Puerta-Alcalde, Sabina Herrera, Montse Tuset, Pedro Castro, Sergio Prieto-Gonzalez, Josep Mensa, José Antonio Martínez, Gemma Sanjuan, J. M. Nicolas, A. del Rio, Jordi Vila, Felipe Garcia, Carolina Garcia-Vidal, Alex Soriano, J. L. Blanco, J. Mallolas, E. Martínez, M. Martínez, J. M. Miró, A. Moreno, M. Solá, A. Ugarte, Ana Gonzalez-Cordón, Montse Laguno, Lorna Leal, John Rojas, Berta Torres, S. Fernandez, A. Tellez, F. Fuentes, E. Sancho, M. Ayala, D. Campubri, M. T. de Alba, M. Fernandez, E. Ferrer, B. Grau, H. Marti, M. Muelas, M. J. Pinazo, N. Rodriguez, M. Roldan, C. Subira, I. Vera, N. Williams, A. Almuedo-Riera, J. Muñoz, A. Aldea, M. Camafort, J. Calvo, A. Capdevila, F. Cardellach, I. Carbonell, E. Coloma, A. Foncillas, R. Estruch, M. Feliu, J. Fernández-Solá, I. Fuertes, C. Gabara, I. Grafia, A. Ladino, R. López-Alfaro, A. López-Soto, I. Macaya, F. Masanés, A. Matas, M. Navarro, J. Marco-Hernández, L. Miguel, J. C. Milisenda, P. Moreno, J. Naval, D. Nicolás, H. Oberoi, J. Padrosa, S. Prieto-González, M. Pellicé, J. Ribot, O. Rodríguez-Núnez, E. Sacanella, F. Seguí, C. Sierra, A. Tomé, M. Torres, H. Ventosa, C. Zamora-Martínez, M. Almela, M. Alvarez, J. Bosch, J. Costa, G. Cuesta, B. Fidalgo, J. Gonzàlez, F. Marco, S. Narvaez, C. Pitart, E. Rubio, A. Vergara, M. E. Valls, Y. Zboromyrska, E. López |
| 70 |
[GO] |
2022―Apr―26 |
Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis |
Shanshan Yang, Shengshu Wang, Mingmei Du, Miao Liu, Yunxi Liu, Yao He |
| 71 |
[GO] |
2022―Apr―21 |
Interferon Treatments for SARS-CoV-2: Challenges and Opportunities |
Diya Jhuti, Angeli Rawat, Christina M. Guo, Lindsay A. Wilson, Edward J. Mills, Jamie I. Forrest |
| 72 |
[GO] |
2022―Mar―21 |
Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan |
Shinya Tsuzuki, Kayoko Hayakawa, Yohei Doi, Tomohiro Shinozaki, Yukari Uemura, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Gen Yamada, Sho Saito, Taro Shibata, Masashi Kondo, Kazuo Izumi, Masayuki Hojo, Tetsuya Mizoue, Kazuhisa Yokota, Fukumi Nakamura-Uchiyama, Fumitake Saito, Wataru Sugiura, Norio Ohmagari |
| 73 |
[GO] |
2022―Mar―10 |
Impact of Early Corticosteroids on Preventing Clinical Deterioration in Non-critically Ill Patients Hospitalized with COVID-19: A Multi-hospital Cohort Study |
Lakshmi Swaminathan, Scott Kaatz, Heather Chubb, Kim Tae, Mayur S. Ramesh, Raef Fadel, Cecilia Big, Jessica Jones, Scott A. Flanders, Hallie C. Prescott |
| 74 |
[GO] |
2022―Feb―18 |
Efficacy and Safety of a Phytopharmaceutical Drug Derived from Cocculus hirsutus in Adults with Moderate COVID-19: a Phase 2, Open-label, Multicenter, Randomized Controlled Trial |
Sadhna Joglekar, Shivakumar S. Iyer, Rohit Parate, Akash A. Khobragade, Rakesh Patil, Shashi Bhushan, Dnyanshwar M. Halnor, Girish C. Rajadhyaksha, Kartikeya Parmar, Shilpi Dhawan, Suyog Mehta, Shashank R. Joshi |
| 75 |
[GO] |
2022―Feb―16 |
Machine Learning-Based COVID-19 Patients Triage Algorithm Using Patient-Generated Health Data from Nationwide Multicenter Database |
Min Sue Park, Hyeontae Jo, Haeun Lee, Se Young Jung, Hyung Ju Hwang |
| 76 |
[GO] |
2022―Feb―04 |
Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study” |
Charles Phillipe de Lucena Alves, Marcelo Rodrigues dos Santos, Daisy Motta-Santos |
| 77 |
[GO] |
2022―Feb―02 |
A Response to: Letter to the Editor Regarding “Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study” |
Ricardo Salgado-Aranda |
| 78 |
[GO] |
2022―Feb―02 |
EpidemiologiCal POpulatioN STudy of SARS-CoV-2 in Lake CounTy, Illinois (CONTACT): Methodology and Baseline Characteristics of a Community-Based Surveillance Study |
Ryan D. Kilpatrick, Olga Sánchez-Soliño, Negar Niki Alami, Christopher Johnson, Yixin Fang, Lani R. Wegrzyn, Whitney S. Krueger, Yizhou Ye, Nancy Dreyer, Gregory C. Gray |
| 79 |
[GO] |
2022―Jan―25 |
Correction to: Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19 |
Ritam Das, Komal Kotra, Pulkit Singh, Belinda Loh, Sebastian Leptihn, Urmi Bajpai |
| 80 |
[GO] |
2022―Jan―20 |
Effect of Tocilizumab Treatment on Patients with Coronavirus Disease 2019 and Bacteremia: A Retrospective Cohort Study |
Masaatsu Kuwahara, Misa Kamigaito, Shou Nitta, Kana Hasegawa, Hiromoto Murakami, Tomoyuki Kobayashi, Kunihiro Shirai, Keisuke Kohama, Jun-ichi Hirata |
| 81 |
[GO] |
2021―Dec―29 |
Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy |
Tobias Homan, Francesca Fortunato, Gaetano Corso, Pier Luigi Lopalco, Rosa Prato, Domenico Martinelli |
| 82 |
[GO] |
2021―Dec―27 |
Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season |
Gaël Dos Santos, Hao Wang, Pooja Jindal, Maria Rybo, Hélène Roul, Sridevi Pallem, Tamara Eckermann, Lode Godderis, Xavier Martínez Gómez, Eric Godard, Muriel Soler, Mitra Yousefi, Ignacio Salamanca de la Cueva, Ugo Nwoji |
| 83 |
[GO] |
2021―Dec―10 |
Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) |
Tommaso Manciulli, Michele Spinicci, Alessandro Bartoloni, Lorenzo Zammarchi |
| 84 |
[GO] |
2021―Dec―10 |
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) |
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, Silvia Corcione, Francesco Giuseppe De Rosa, Fabiano Di Marco, Andrea Gori, Andrea Gramegna, Guido Granata, Angelo Gratarola, Alberto Enrico Maraolo, Malgorzata Mikulska, Andrea Lombardi, Federico Pea, Nicola Petrosillo, Dejan Radovanovic, Pierachille Santus, Alessio Signori, Emanuela Sozio, Elena Tagliabue, Carlo Tascini, Carlo Vancheri, Antonio Vena, Pierluigi Viale, Francesco Blasi |
| 85 |
[GO] |
2021―Dec―08 |
A Randomized, Double-Blind, Placebo-Controlled, First-in-Human Clinical Trial to Assess Safety, Tolerability, and Pharmacokinetics of LY-CovMab, a Potent Human Neutralizing Antibody Against SARS-CoV-2 |
Qian Zhang, Renpeng Zhou, Jingjing Yang, Changlin Dou, Tianyi Gan, Fujia Liu, Baihui Hu, Deyong Song, Chao Lu, Wei Hu |
| 86 |
[GO] |
2021―Dec―03 |
Short-Term Immunogenicity Profiles and Predictors for Suboptimal Immune Responses in Patients with End-Stage Kidney Disease Immunized with Inactivated SARS-CoV-2 Vaccine |
Sarinya Boongird, Piyatida Chuengsaman, Chavachol Setthaudom, Arkom Nongnuch, Montira Assanatham, Salinnart Phanprasert, Rungthiwa Kitpermkiat, Sasisopin Kiertiburanakul, Kumthorn Malathum, Angsana Phuphuakrat, Andrew Davenport, Jackrapong Bruminhent |
| 87 |
[GO] |
2021―Nov―24 |
Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection |
Eszter Fodor, Veronika Müller, Zsolt Iványi, Tímea Berki, Olga Kuten Pella, István Hornyák, Mira Ambrus, Ágnes Sárkány, Árpád Skázel, Ágnes Madár, Dorottya Kardos, Gábor Kemenesi, Fanni Földes, Sándor Nagy, Andrea Matusovits, Nacsa János, Attila Tordai, Ferenc Jakab, Zsombor Lacza |
| 88 |
[GO] |
2021―Nov―22 |
Alternative Treatment Strategies for Secondary Bacterial and Fungal Infections Associated with COVID-19 |
Ritam Das, Komal Kotra, Pulkit Singh, Belinda Loh, Sebastian Leptihn, Urmi Bajpai |
| 89 |
[GO] |
2021―Nov―14 |
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of a Novel Inhaled Biologic Therapeutic in Adults with Respiratory Distress Secondary to COVID-19 Infection |
Michael Roshon, Luciano Lemos-Filho, Holli Cherevka, Laura Goldberg, Kristin Salottolo, David Bar-Or |
| 90 |
[GO] |
2021―Nov―11 |
Lack of Prognostic Value of SARS-CoV2 RT-PCR Cycle Threshold in the Community |
Miguel J. Martínez, Luca Basile, Antoni Sisó-Almirall, Victor Cristino, Genoveva Cuesta, Juan Carlos Hurtado, Mariana Fernandez-Pittol, María Mar Mosquera, Alex Soriano, Ana Martínez, Mª Angeles Marcos, Jordi Vila, Climent Casals-Pascual |
| 91 |
[GO] |
2021―Nov―10 |
Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials |
Thundon Ngamprasertchai, Rattagan Kajeekul, Chaisith Sivakorn, Narisa Ruenroegnboon, Viravarn Luvira, Tanaya Siripoon, Nantasit Luangasanatip |
| 92 |
[GO] |
2021―Oct―28 |
Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data |
Natalia A. Díaz, Rosa de Miguel, Fernando Agüero, Omar Sued, José R. Arribas, Juan Ambrosioni, Juan Ambrosioni, José L. Blanco, Lorena de la Mora, Felipe García-Alcaide, Ana González-Cordón, Alexis Inciarte, Montserrat Laguno, Lorna Leal, Esteban Martínez-Chamorro, María Martínez-Rebollar, José M. Miró, Jhon F. Rojas, Berta Torres, Josep Mallolas, Laia Albiac, Daiana L. Agüero, Marta Bodro, Celia Cardozo, Mariana Chumbita, Nicol García, Carolina García-Vidal, Marta M. Hernández-Meneses, Sabina Herrera, Laura Linares, Antonio Moreno, Laura Morata, Jose A. Martínez-Martínez, Pedro Puerta, Verónica Rico, Alex Soriano, Mikel Martínez, María del Mar Mosquera, María A. Marcos, Jordi Vila, Montse Tuset, Dolors Soy, Anna Vilella, Alex Almuedo, María J. Pinazo, José Muñoz |
| 93 |
[GO] |
2021―Oct―25 |
Epidemiology of Viruses Causing Pediatric Community Acquired Pneumonia in Shanghai During 2010-2020: What Happened Before and After the COVID-19 Outbreak? |
Fei Li, Yuhan Zhang, Peng Shi, Linfeng Cao, Liyun Su, Yulan Zhang, Ke Peng, Roujian Lu, Wenjie Tan, Jun Shen |
| 94 |
[GO] |
2021―Oct―23 |
Long-Term Effects of COVID-19 on Health Care Workers 1-Year Post-Discharge in Wuhan |
Tingting Liao, Daquan Meng, Lijuan Xiong, Shuting Wu, Lian Yang, Sufei Wang, Mei Zhou, Xinliang He, Xiongjing Cao, Huangguo Xiong, Yunzhou Fan, Jiahong Xia, Yu Hu, Yang Jin |
| 95 |
[GO] |
2021―Sep―28 |
In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses |
Manjunath Shet, Rosa Hong, David Igo, Marc Cataldo, Sailaja Bhaskar |
| 96 |
[GO] |
2021―Sep―16 |
Antibiotic Prescriptions Targeting Bacterial Respiratory Infections in Admitted Patients with COVID-19: A Prospective Observational Study |
Johan Van Laethem, Stephanie Wuyts, Sven Van Laere, Silke Dirkx, Lucie Seyler, Rembert Mertens, Bart Ilsen, Patrick Lacor, Denis Pierard, Sabine D. Allard |
| 97 |
[GO] |
2021―Sep―02 |
Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) |
Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, Silvia Corcione, Francesco Giuseppe De Rosa, Fabiano Di Marco, Andrea Gori, Andrea Gramegna, Guido Granata, Angelo Gratarola, Alberto Enrico Maraolo, Malgorzata Mikulska, Andrea Lombardi, Federico Pea, Nicola Petrosillo, Dejan Radovanovic, Pierachille Santus, Alessio Signori, Emanuela Sozio, Elena Tagliabue, Carlo Tascini, Carlo Vancheri, Antonio Vena, Pierluigi Viale, Francesco Blasi, Matteo Bassetti, Daniele Roberto Giacobbe, Paolo Bruzzi, Emanuela Barisione, Stefano Centanni, Nadia Castaldo, Silvia Corcione, Francesco Giuseppe De Rosa, Fabiano Di Marco, Andrea Gori, Andrea Gramegna, Guido Granata, Angelo Gratarola, Alberto Enrico Maraolo, Malgorzata Mikulska, Andrea Lombardi, Federico Pea, Nicola Petrosillo, Dejan Radovanovic, Pierachille Santus, Alessio Signori, Emanuela Sozio, Elena Tagliabue, Carlo Tascini, Carlo Vancheri, Antonio Vena, Pierluigi Viale, Francesco Blasi |
| 98 |
[GO] |
2021―Aug―30 |
Reversal of SARS-CoV2-Induced Hypoxia by Nebulized Sodium Ibuprofenate in a Compassionate Use Program |
Oscar Salva, Pablo A. Doreski, Celia S. Giler, Dario C. Quinodoz, Lucia G. Guzmán, Sonia E. Muñoz, Mariana N. Carrillo, Daniela J. Porta, Germán Ambasch, Esteban Coscia, Jorge L. Tambini Diaz, Germán D. Bueno, Jorge O. Fandi, Miriam A. Maldonado, Leandro E. Peña Chiappero, Fernando Fournier, Hernán A. Pérez, Mauro A. Quiroga, Javier A. Sala Mercado, Carlos Martínez Picco, Marcelo Alejandro Beltrán, Luis A. Argañarás, Nicolás Martínez Ríos, Galia I. Kalayan, Dante M. Beltramo, Néstor H. García |
| 99 |
[GO] |
2021―Aug―27 |
Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial |
Masaharu Shinkai, Kenji Tsushima, Shingo Tanaka, Eri Hagiwara, Norihito Tarumoto, Ichiro Kawada, Yuji Hirai, Sho Fujiwara, Yuko Komase, Takeshi Saraya, Hidefumi Koh, Naho Kagiyama, Megumi Shimada, Daiki Kanou, Shinichi Antoku, Yujiro Uchida, Yutaka Tokue, Mikio Takamori, Yasuhiro Gon, Kenya Ie, Yoshitaka Yamazaki, Kazumasa Harada, Naoki Miyao, Takashi Naka, Mitsunaga Iwata, Atsushi Nakagawa, Kazutoshi Hiyama, Yoshihiko Ogawa, Masahiro Shinoda, Shinichiro Ota, Takatomo Hirouchi, Jiro Terada, Shuichi Kawano, Takashi Ogura, Tsutomu Sakurai, Yoshihiko Matsumoto, Hiroyuki Kunishima, Osamu Kobayashi, Satoshi Iwata |
| 100 |
[GO] |
2021―Aug―25 |
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern |
Marco Falcone, Giusy Tiseo, Beatrice Valoriani, Chiara Barbieri, Sara Occhineri, Paola Mazzetti, Maria Linda Vatteroni, Lorenzo Roberto Suardi, Niccolò Riccardi, Mauro Pistello, Danilo Tacconi, Francesco Menichetti |
| 101 |
[GO] |
2021―Aug―25 |
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals |
Soumya Jaganathan, Francis Stieber, Sonia N. Rao, Vladyslav Nikolayevskyy, Davide Manissero, Nadia Allen, Jeff Boyle, Jenny Howard |
| 102 |
[GO] |
2021―Aug―13 |
Efficacy and Safety of Corticosteroid Use in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis |
Yuqing Cui, Yali Sun, Junyi Sun, Huoyan Liang, Xianfei Ding, Xueyi Sun, Dong Wang, Tongwen Sun |
| 103 |
[GO] |
2021―Aug―13 |
Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection |
Yuying Chen, Da Huang, Wei Yuan, Jiang Chang, Zhize Yuan, Di Wu, Meifang Han, Xiaoping Luo, Qin Ning, Weiming Yan |
| 104 |
[GO] |
2021―Aug―10 |
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial |
Mohammad Bosaeed, Ebrahim Mahmoud, Ahmad Alharbi, Hadeel Altayib, Hawra Albayat, Faisal Alharbi, Khalid Ghalilah, Abdulmajid Al Arfaj, Jumana AlJishi, Abdullatif Alarfaj, Hajar Alqahtani, Badriah M. Almutairi, Manar Almaghaslah, Nawaf M. Alyahya, Abdullah Bawazir, Saud AlEisa, Abdulrahman Alsaedy, Abderrezak Bouchama, Malak Alharbi, Majid AlShamrani, Sameera Al Johani, Majed Aljeraisy, Mohammed Alzahrani, Abdulhakeem O. Althaqafi, Hassan Almarhabi, Athari Alotaibi, Nasser Alqahtani, Yaseen M. Arabi, Omar S. Aldibasi, Ahmad Alaskar |
| 105 |
[GO] |
2021―Aug―10 |
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial |
Konstantinos Tsiakos, Antonios Tsakiris, Georgios Tsibris, Pantazis-Michael Voutsinas, Periklis Panagopoulos, Maria Kosmidou, Vasileios Petrakis, Areti Gravvani, Theologia Gkavogianni, Eleftherios Klouras, Konstantina Katrini, Panagiotis Koufargyris, Iro Rapti, Athanassios Karageorgos, Emmanouil Vrentzos, Christina Damoulari, Vagia Zarkada, Chrysanthi Sidiropoulou, Sofia Artemi, Anastasios Ioannidis, Androniki Papapostolou, Evangelos Michelakis, Maria Georgiopoulou, Dimitra-Melia Myrodia, Panteleimon Tsiamalos, Konstantinos Syrigos, George Chrysos, Thomas Nitsotolis, Haralampos Milionis, Garyphallia Poulakou, Evangelos J. Giamarellos-Bourboulis |
| 106 |
[GO] |
2021―Aug―10 |
Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure |
Yuichiro Shindo, Yasuhiro Kondoh, Akiko Kada, Yohei Doi, Keisuke Tomii, Hiroshi Mukae, Naohiko Murata, Ryosuke Imai, Masaki Okamoto, Yasuhiko Yamano, Yasunari Miyazaki, Masahiro Shinoda, Hiromichi Aso, Shinyu Izumi, Haruyuki Ishii, Ryota Ito, Akiko M. Saito, Toshiki I. Saito, Yoshinori Hasegawa |
| 107 |
[GO] |
2021―Aug―10 |
A Narrative Review of the Clinical Practicalities of Bamlanivimab and Etesevimab Antibody Therapies for SARS-CoV-2 |
Ramesh Nathan, Imad Shawa, Inmaculada De La Torre, Jennifer M. Pustizzi, Natalie Haustrup, Dipak R. Patel, Gregory Huhn |
| 108 |
[GO] |
2021―Aug―09 |
Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2 |
Elena Riester, Mario Majchrzak, Annelies Mühlbacher, Caroline Tinguely, Peter Findeisen, Johannes Kolja Hegel, Michael Laimighofer, Christopher M. Rank, Kathrin Schönfeld, Florina Langen, Tina Laengin, Christoph Niederhauser |
| 109 |
[GO] |
2021―Aug―09 |
Multicenter Evaluation of a Fully Automated High-Throughput SARS-CoV-2 Antigen Immunoassay |
Dominik Nörz, Flaminia Olearo, Stojan Perisic, Matthias F. Bauer, Elena Riester, Tanja Schneider, Kathrin Schönfeld, Tina Laengin, Marc Lütgehetmann |
| 110 |
[GO] |
2021―Jul―23 |
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series |
Emanuela Messina, Anna Danise, Giulio Ferrari, Andrea Andolina, Matteo Chiurlo, Marie Razanakolona, Maxime Barakat, Robert J. Israel, Antonella Castagna |
| 111 |
[GO] |
2021―Jul―22 |
Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations |
Fei Chen, Lanting Hao, Shiheng Zhu, Xinyuan Yang, Wenhao Shi, Kai Zheng, Tenger Wang, Huiran Chen |
| 112 |
[GO] |
2021―Jul―14 |
Epidemiology and Incidence of COVID-19-Associated Pulmonary Aspergillosis (CAPA) in a Greek Tertiary Care Academic Reference Hospital |
Elisabeth Paramythiotou, George Dimopoulos, Nikolaos Koliakos, Maria Siopi, Sophia Vourli, Spyros Pournaras, Joseph Meletiadis |
| 113 |
[GO] |
2021―Jul―12 |
COVID-19: Zinc and Angiotensin-Converting Enzyme 2 (ACE2) Deficiencies as Determinants of Risk and Severity of Disease: A Narrative Review |
Miklos P. Salgo |
| 114 |
[GO] |
2021―Jul―11 |
Systematic Review and Subgroup Meta-analysis of Randomized Trials to Determine Tocilizumab’s Place in COVID-19 Pneumonia |
Timothée Klopfenstein, Vincent Gendrin, Aurélie Gerazime, Thierry Conrozier, Jean-Charles Balblanc, Pierre-Yves Royer, Anne Lohse, Chaouki Mezher, Lynda Toko, Cerise Guillochon, Julio Badie, Alix Pierron, N.’dri Juliette Kadiane-Oussou, Marc Puyraveau, Souheil Zayet |
| 115 |
[GO] |
2021―Jul―10 |
Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection |
Marc Scherlinger, Renaud Felten, Floriane Gallais, Charlotte Nazon, Emmanuel Chatelus, Luc Pijnenburg, Amaury Mengin, Adrien Gras, Pierre Vidailhet, Rachel Arnould-Michel, Sabrina Bibi-Triki, Raphaël Carapito, Sophie Trouillet-Assant, Magali Perret, Alexandre Belot, Seiamak Bahram, Laurent Arnaud, Jacques-Eric Gottenberg, Samira Fafi-Kremer, Jean Sibilia |
| 116 |
[GO] |
2021―Jul―09 |
Efficacy and Safety of Tocilizumab Treatment COVID-19 Patients: A Case-Control Study and Meta-Analysis |
Weijun Jiang, Weiwei Li, Qiuyue Wu, Ying Han, Jing Zhang, Tao Luo, Yanju Guo, Yang Yang, Peiran Zhu, Xinyi Xia |
| 117 |
[GO] |
2021―Jun―21 |
Long-Term Patient-Centred Follow-up in a Prospective Cohort of Patients with COVID-19 |
Elda Righi, Massimo Mirandola, Fulvia Mazzaferri, Elisa Razzaboni, Amina Zaffagnini, Anna Erbogasto, Ilaria Dalla Vecchia, Nina Auerbach, Federico Ivaldi, Maria Mongardi, Pietro Minuz, Michele Milella, Sara Mehrabi, Oliviero Olivieri, Domenico Girelli, Enrico Polati, Claudio Micheletto, Evelina Tacconelli |
| 118 |
[GO] |
2021―Jun―16 |
The Role of Macrolides for the Management of Community-Acquired Pneumonia and Pneumonia by the Novel Coronavirus SARS-CoV-2 (COVID-19): A Position Paper by Four Medical Societies from Greece |
Evangelos J. Giamarellos-Bourboulis, George L. Daikos, Panagiotis Gargalianos, Charalambos Gogos, Marios Lazanas, Periklis Panagopoulos, Garyphallia Poulakou, Helen Sambatakou, Michael Samarkos |
| 119 |
[GO] |
2021―Jun―16 |
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients |
Raquel Rubio-Acero, Noemi Castelletti, Volker Fingerle, Laura Olbrich, Abhishek Bakuli, Roman Wölfel, Philipp Girl, Katharina Müller, Simon Jochum, Matthias Strobl, Michael Hoelscher, Andreas Wieser, Emad Alamoudi, Jared Anderson, Valeria Baldassare, Maximilian Baumann, Marieke Behlen, Marc Becker, Jessica Beyerl, Rebecca Böhnlein, Isabel Brand, Anna Brauer, Vera Britz, Jan Bruger, Friedrich Caroli, Lorenzo Contento, Alina Czwienzek, Flora Deák, Emma Dech, Laura Dech, Maximillian N. Diefenbach, Jana Diekmannshemke, Anna Do, Gerhard Dobler, Ute Eberle, Juergen Durner, Ute Eberle, Judith Eckstein, Tabea Eser, Philine Falk, Jonathan Frese, Stefanie Fischer, Felix Forster, Turid Frahnow, Jonathan Frese, Günter Fröschl, Christiane Fuchs, Mercè Garí, Marius Gasser, Sonja Gauder, Otto Geisenberger, Christof Geldmacher, Kristina Gillig, Elias Golschan, Vitus Grauvogl, Jessica Michelle Guggenbuehl Noller, Celina Halfmann, Tim Haselwarter, Jan Hasenauer, Arlett Heiber, Matthias Herrmann, Stefan Hillmann, Christian Hinske, Janna Hoefflin, Tim Hofberger, Michael Höfinger, Larissa Hoffmann, Sacha Horn, Kristina Huber, Christian Janke, Ursula Kappl, Charlotte Kiani, Isabel Klugherz, Norah Kreider, Inge Kroidl, Arne Kroidl, Magdalena Lang, Clemens Lang, Silvan Lange, Ekaterina Lapteva, Michael Laxy, Ronan Le Gleut, Reiner Leidl, Felix Lindner, Alexander Maczka, Alicia Markgraf, Paula Matcau, Rebecca Mayrhofer, Anna-Maria Mekota, Hannah Müller, Dafni Metaxa, Leonie Pattard, Ivana Paunovic, Claire Pleimelding, Michel Pletschette, Michael Pritsch, Stephan Prückner, Kerstin Puchinger, Konstantin Pusl, Peter Pütz, Katja Radon, Elba Raimúndez, Julius Raschka, Jakob Reich, Friedrich Riess, Camila Rothe, Elmar Saathoff, Nicole Schäfer, Yannik Schälte, Paul Schandelmaier, Lara Schneider, Sophie Schultz, Mirjam Schunk, Lars Schwettmann, Heidi Seibold, Peter Sothmann, Paul Stapor, Jeni Tang, Fabian Theis, Verena Thiel, Sophie Thiesbrummel, Eva Thumser, Niklas Thur, Julian Ullrich, Julia Waibel, Claudia Wallrauch, Simon Winter, Julia Wolff, Pia Wullinger, Tobias Würfel, Patrick Wustrow, Houda Yaqine, Sabine Zange, Eleftheria Zeggini, Thomas Zimmermann, Lea Zuche |
| 120 |
[GO] |
2021―Jun―14 |
A Novel Prediction Model of COVID-19 Progression: A Retrospective Cohort Study |
Wei Xu, ChenLu Huang, Ling Fei, WeiXia Li, XuDong Xie, Qiang Li, Liang Chen |
| 121 |
[GO] |
2021―Jun―13 |
Reduction in Sporadic Norovirus Infections Following the Start of the COVID-19 Pandemic, 2019-2020, Philadelphia |
Irving Nachamkin, Melissa Richard-Greenblatt, Mei Yu, Hong Bui |
| 122 |
[GO] |
2021―Jun―11 |
Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19 |
Fernanda Meira, Estela Moreno-García, Laura Linares, Irene Macaya, Adria Tomé, Marta Hernández-Meneses, Laia Albiach, Laura Morata, Laura Letona, Marta Bodro, Alberto Cózar-Llistó, Celia Cardozo, Mariana Chumbita, Cristina Pitart, Juan Ambrosioni, Verónica Rico, Daiana Agüero, Pedro Puerta-Alcalde, Nicole Garcia-Pouton, Francesc Marco, Carolina Garcia-Vidal, Alex Soriano, José Antonio Martínez |
| 123 |
[GO] |
2021―Jun―10 |
Dynamic Changes in the Immune Response Correlate with Disease Severity and Outcomes During Infection with SARS-CoV-2 |
Fang Zheng, Ruochan Chen, Run Yao, Yaxiong Huang, Xin Tan, Jiyang Liu, Ning Li, Yuanlin Xie |
| 124 |
[GO] |
2021―May―29 |
Dynamic Antibody Responses in Patients with Different Severity of COVID-19: A Retrospective Study |
Wanrong Lu, Ping Wu, Liang He, Yifan Meng, Peng Wu, Wencheng Ding, Jia Liu |
| 125 |
[GO] |
2021―May―11 |
Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia |
Matthew Geriak, Fadi Haddad, Ravina Kullar, Kristina L. Greenwood, MacKenzie Habib, Cole Habib, David Willms, George Sakoulas |
| 126 |
[GO] |
2021―May―03 |
Prevalence and Mortality due to COVID-19 in HIV Co-Infected Population: A Systematic Review and Meta-Analysis |
Min Liang, Ning Luo, Mafeng Chen, Chunna Chen, Shivank Singh, Shantanu Singh, Shifan Tan |
| 127 |
[GO] |
2021―Apr―29 |
A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort |
Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferrán Torres, Ana Fernández-Cruz |
| 128 |
[GO] |
2021―Apr―29 |
Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study |
Rajesh Naidu Janapala, Jigar Patel, Omar Belfaqeeh, Abdulla Alhashmi, Ali Pourmand |
| 129 |
[GO] |
2021―Apr―07 |
Pharmacokinetic and Pharmacodynamic Evaluation of Ravulizumab in Adults with Severe Coronavirus Disease 2019 |
Alanna C. McEneny-King, Jonathan P. R. Monteleone, Shamsah D. Kazani, Stephan R. Ortiz |
| 130 |
[GO] |
2021―Mar―31 |
A Novel Prediction Model for Long-Term SARS-CoV-2 RNA Shedding in Non-Severe Adult Hospitalized Patients with COVID-19: A Retrospective Cohort Study |
Chen Lu Huang, Ling Fei, WeiXia Li, Wei Xu, Xu Dong Xie, Qiang Li, Liang Chen |
| 131 |
[GO] |
2021―Mar―22 |
A Survey of Provider-Reported Use and Perceived Effectiveness of Medications for Symptom Management in Telemedicine and Outpatient Visits for Mild COVID-19 |
James B. O’Keefe, Lydia C. Newsom, Thomas H. Taylor |
| 132 |
[GO] |
2021―Mar―18 |
Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach |
Hsiao-Hsuan Jen, Wei-Jung Chang, Ting-Yu Lin, Chen-Yang Hsu, Amy Ming-Fang Yen, Chao-Chih Lai, Tony Hsiu-Hsi Chen |
| 133 |
[GO] |
2021―Mar―14 |
Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study |
Ricardo Salgado-Aranda, Nicasio Pérez-Castellano, Ivan Núñez-Gil, A. Josué Orozco, Norberto Torres-Esquivel, Jesús Flores-Soler, Ahmed Chamaisse-Akari, Angela Mclnerney, Carlos Vergara-Uzcategui, Lin Wang, Juan J. González-Ferrer, David Filgueiras-Rama, Victoria Cañadas-Godoy, Carlos Macaya-Miguel, Julián Pérez-Villacastín |
| 134 |
[GO] |
2021―Feb―24 |
A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study |
Paul K. Drain, Madhavi Ampajwala, Christopher Chappel, Andre B. Gvozden, Melanie Hoppers, Melody Wang, Robert Rosen, Stephen Young, Edward Zissman, Michalina Montano |
| 135 |
[GO] |
2021―Feb―02 |
Computational and Experimental Studies Reveal That Thymoquinone Blocks the Entry of Coronaviruses Into In Vitro Cells |
Huan Xu, Bing Liu, Zhen Xiao, Meiling Zhou, Lin Ge, Fan Jia, Yanling Liu, Hongshan Jin, Xiuliang Zhu, Jian Gao, Javed Akhtar, Bai Xiang, Ke Tan, Guanyu Wang |
| 136 |
[GO] |
2021―Jan―25 |
COVID-19: Before the Fall, An Evidence-Based Narrative Review of Treatment Options |
Nicholas Rebold, Dana Holger, Sara Alosaimy, Taylor Morrisette, Michael Rybak |
| 137 |
[GO] |
2021―Jan―23 |
The Efficacy and Safety of Hydroxychloroquine in Patients with COVID-19: A Multicenter National Retrospective Cohort |
Abdulkarim Abdulrahman, Islam AlSayed, Marwa AlMadhi, Jumana AlArayed, Sara Jaafar Mohammed, Aesha Khalid Sharif, Khadija Alansari, Abdulla Ismael AlAwadhi, Manaf AlQahtani |
| 138 |
[GO] |
2021―Jan―22 |
Clinical Characteristics of Patients with Severe and Critical COVID-19 in Wuhan: A Single-Center, Retrospective Study |
Zhaohui Chen, Junyi Hu, Lilong Liu, Youpeng Zhang, Dandan Liu, Ming Xiong, Yi Zhao, Ke Chen, Yu-Mei Wang |
| 139 |
[GO] |
2021―Jan―12 |
Clinical Diagnostic Study of a Novel Injection Molded Swab for SARS-Cov-2 Testing |
Joshua K. Tay, Gail B. Cross, Louisa Sun, Alfred Chia, Jeremy Chee, Jerold Loh, Zhen Yu Lim, Nicholas Ngiam, Wen Pang Khang, Stephanie Yeap, Han Lee Goh, Chor Hiang Siow, Woei Shyang Loh, Kwok Seng Loh, Chun Kiat Lee, Benedict Yan, Vincent T. K. Chow, De Yun Wang, Freddy Boey, John E. L. Wong, David M. Allen |
| 140 |
[GO] |
2021―Jan―09 |
Filling the Gap Until Full Vaccine Deployment in the War on Coronavirus Disease-19 |
Sabrina Mattoli |
| 141 |
[GO] |
2021―Jan―08 |
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study |
Antonio Vena, Lucia Taramasso, Antonio Di Biagio, Malgorzata Mikulska, Chiara Dentone, Andrea De Maria, Laura Magnasco, Laura Ambra Nicolini, Bianca Bruzzone, Giancarlo Icardi, Andrea Orsi, Paolo Pelosi, Lorenzo Ball, Denise Battaglini, Iole Brunetti, Maurizio Loconte, Nicolò A. Patroniti, Chiara Robba, Martina Bavastro, Matteo Cerchiaro, Daniele Roberto Giacobbe, Irene Schiavetti, Marco Berruti, Matteo Bassetti |
| 142 |
[GO] |
2020―Dec―06 |
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study |
Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferrán Torres, Víctor Moreno-Torres, Itziar de Pablo-López, Paulina García-López, Francisco Abad-Santos, Clara M. Rosso-Fernández, Ana Aldea-Perona, Eva Montané, Ruth M. Aparicio-Hernández, Roser Llop-Rius, Consuelo Pedrós, Paloma Gijón, Carolina Hernández-Carballo, María J. Pedrosa-Martínez, Consuelo Rodríguez-Jiménez, Guillermo Prada-Ramallal, Lourdes Cabrera-García, Josefa A. Aguilar-García, Rocío Sanjuan-Jimenez, Evelyn I. Ortiz-Barraza, Enrique Sánchez-Chica, Ana Fernández-Cruz |
| 143 |
[GO] |
2020―Nov―26 |
Correction to: Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains |
Eriko Padron-Regalado |
| 144 |
[GO] |
2020―Nov―09 |
Correction to: Early Treatment of COVID-19 Disease: A Missed Opportunity |
Jamie I. Forrest, Craig R. Rayner, Jay J. H. Park, Edward J. Mills |
| 145 |
[GO] |
2020―Nov―02 |
Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study |
Laila Carolina Abu Esba, Rahaf Ali Alqahtani, Abin Thomas, Nour Shamas, Lolowa Alswaidan, Gahdah Mardawi |
| 146 |
[GO] |
2020―Oct―28 |
Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes |
Juan Huang, Lin Zhu, Xiangli Bai, Xiong Jia, Yajing Lu, Aiping Deng, Juyi Li, Si Jin |
| 147 |
[GO] |
2020―Oct―16 |
Chest CT Features of 182 Patients with Mild Coronavirus Disease 2019 (COVID-19) Pneumonia: A Longitudinal, Retrospective and Descriptive Study |
Huaping Liu, Shiyong Luo, Youming Zhang, Yuzhu Jiang, Yuting Jiang, Yayi Wang, Hailan Li, Chiyao Huang, Shunzhen Zhang, Xili Li, Yiqing Tan, Wei Wang |
| 148 |
[GO] |
2020―Oct―13 |
Early Treatment of COVID-19 Disease: A Missed Opportunity |
Jamie I. Forrest, Craig R. Rayner, Jay J. H. Park, Edward J. Mills |
| 149 |
[GO] |
2020―Sep―28 |
Effect of Corticosteroid Therapy on the Duration of SARS-CoV-2 Clearance in Patients with Mild COVID-19: A Retrospective Cohort Study |
Cheng Ding, Xuewen Feng, Yanfei Chen, Jing Yuan, Ping Yi, Yongtao Li, Qin Ni, Rongrong Zou, Xiaohe Li, Jifang Sheng, Lanjuan Li, Kaijin Xu |
| 150 |
[GO] |
2020―Sep―20 |
Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial |
Danyal Ibrahim, Latha Dulipsingh, Lisa Zapatka, Reginald Eadie, Rebecca Crowell, Kendra Williams, Dorothy B. Wakefield, Lisa Cook, Jennifer Puff, Syed A. Hussain |
| 151 |
[GO] |
2020―Sep―16 |
Steroids and COVID-19: We Need a Precision Approach, Not One Size Fits All |
Grant W. Waterer, Jordi Rello |
| 152 |
[GO] |
2020―Sep―04 |
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare Professionals |
Georg M. N. Behrens, Anne Cossmann, Metodi V. Stankov, Bianca Schulte, Hendrik Streeck, Reinhold Förster, Berislav Bosnjak, Stefanie Willenzon, Anna-Lena Boeck, Anh Thu Tran, Thea Thiele, Theresa Graalmann, Moritz Z. Kayser, Anna Zychlinsky Scharff, Christian Dopfer, Alexander Horke, Isabell Pink, Torsten Witte, Martin Wetzke, Diana Ernst, Alexandra Jablonka, Christine Happle |
| 153 |
[GO] |
2020―Sep―02 |
Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study |
Qiang Li, Weixia Li, Yinpeng Jin, Wei Xu, Chenlu Huang, Li Li, Yuxian Huang, Qingchun Fu, Liang Chen |
| 154 |
[GO] |
2020―Aug―18 |
Correction to: A Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 |
Sonia N. Rao, Davide Manissero, Victoria R. Steele, Josep Pareja |
| 155 |
[GO] |
2020―Aug―12 |
Interleukin-6 Blocking vs. JAK-STAT Inhibition for Prevention of Lung Injury in Patients with COVID-19 |
Joseph Meletiadis, Sotirios Tsiodras, Panagiotis Tsirigotis |
| 156 |
[GO] |
2020―Aug―01 |
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse |
Taylor Morrisette, Thomas P. Lodise, Marc H. Scheetz, Srijib Goswami, Jason M. Pogue, Michael J. Rybak |
| 157 |
[GO] |
2020―Jul―28 |
A Narrative Systematic Review of the Clinical Utility of Cycle Threshold Values in the Context of COVID-19 |
Sonia N. Rao, Davide Manissero, Victoria R. Steele, Josep Pareja |
| 158 |
[GO] |
2020―Jul―10 |
That Escalated Quickly: Remdesivir's Place in Therapy for COVID-19 |
Matthew R. Davis, Erin K. McCreary, Jason M. Pogue |
| 159 |
[GO] |
2020―Jul―08 |
Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease |
Danielle E. Anderson, Velraj Sivalingam, Adrian Eng Zheng Kang, Abhishek Ananthanarayanan, Harsha Arumugam, Timothy M. Jenkins, Yacine Hadjiat, Maren Eggers |
| 160 |
[GO] |
2020―May―30 |
COVID-19: An Alert to Ventilator-Associated Bacterial Pneumonia |
Helvécio Cardoso Corrêa Póvoa, Gabriela Ceccon Chianca, Natalia Lopes Pontes Póvoa Iorio |
| 161 |
[GO] |
2020―May―27 |
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review |
David C. Fajgenbaum, Johnson S. Khor, Alexander Gorzewski, Mark-Avery Tamakloe, Victoria Powers, Joseph J. Kakkis, Mileva Repasky, Anne Taylor, Alexander Beschloss, Laura Hernandez-Miyares, Beatrice Go, Vivek Nimgaonkar, Madison S. McCarthy, Casey J. Kim, Ruth-Anne Langan Pai, Sarah Frankl, Philip Angelides, Joanna Jiang, Rozena Rasheed, Erin Napier, Duncan Mackay, Sheila K. Pierson |
| 162 |
[GO] |
2020―Apr―23 |
Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains |
Eriko Padron-Regalado |
| 163 |
[GO] |
2020―Apr―08 |
Coronavirus: Update Related to the Current Outbreak of COVID-19 |
Giovanni Gabutti, Erica d’Anchera, Federica Sandri, Marta Savio, Armando Stefanati |
|
